Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07489443 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum
A NA study, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07489443: Recruiting NA study, sponsored by University of Pittsburgh.
NCT07489443 is a NA study that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07489443, a NA study, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Using both tobacco and cannabis during pregnancy is more common in minoritized groups and can make quitting smoking in pregnancy and remaining smoke free postpartum difficult. Investigators will test an intervention to address prenatal depressive symptoms to encourage people to quit tobacco and cannabis during pregnancy and stay quit postpartum.
Primary Outcome
Rate of attendance will be measured by proportion of sessions attended to total available sessions.
Interventions
- BEHAVIORAL Perinatal smoking cessation treatment and maintenance sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-06-17 |
| Est. Completion | 2027-10 |
| Phase | NA |
What NCT07489443 shows while recruiting
NCT07489443 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Perinatal smoking cessation treatment and maintenance sessions is the first listed.
NCT07489443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07489443 about?
NCT07489443 is a clinical study titled "Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum". Using both tobacco and cannabis during pregnancy is more common in minoritized groups and can make quitting smoking in pregnancy and remaining smoke free postpartum difficult. Investigators will test an intervention to address prenatal depressive symptoms to encourage people to quit tobacco and cann...
What is the current status of trial NCT07489443?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-06-17. Estimated completion is 2027-10.
What interventions are being tested in trial NCT07489443?
The interventions under investigation include: Perinatal smoking cessation treatment and maintenance sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT07489443?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07489443's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI